[1] Osaki M,Oshimura M,Ito H. PI3K-Akt pathway:its functions and alterations in human cancer [J]. 2004,9(6):667-676.[2] Kim SH,Juhnn YS,Kang S,et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt [J]. Cell Mol Life Sci,2006,63(7-8):930-938.[3] Levine DA,Bogomolniy F,Yee CJ,et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers [J]. Clin Cancer Res,2005,11(8):2875-2878.[4] Oda K,Stokoe D,Taketani Y,et al. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma [J]. Cancer Res,2005,65(23):10669-10673.[5] Ware MD,Rosten P,Damen JE,et al. Cloning and characterization of human SHIP,the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation [J]. Blood,1996,88(8):2833-2840.[6] Giri D,Ittmann M. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma [J]. Hum Pathol,1999,30(4):419-424.[7] 张天彪,许丹,关一夫. RECK和MMP-2在口腔鳞癌中的表达及其与侵袭转移关系研究[J]. 中国实用口腔科杂志,2010,3(5):292-294.[8] Xing W,Hamaguchi M. Effects of SHIP-1 on MMP2 secretion and invasion of SR3Y1 cells [J]. J Genet Genomics,2007,34(4):285-293.